Medical News

RSS

Royal Philips Electronics launches new iE33 xMATRIX cardiac ultrasound system

Royal Philips Electronics today announced the enhanced iE33 xMATRIX cardiac ultrasound system featuring a new ergonomic solution for more efficient adult echocardiograms, the X5-1 transducer. With this enhanced technology, Philips continues its tradition of simplified, patient-focused healthcare solutions by providing a more complete imaging solution.

From Philips Healthcare 30 Aug 2010

Trius commences oral torezolid phosphate Phase 3 clinical study for ABSSSI

Trius Therapeutics, Inc. announced that the first patient has been dosed in its Phase 3 clinical study of the oral dosage form of torezolid phosphate for the treatment of acute bacterial skin and skin structure infections (ABSSSI). The double-blind, active control, pivotal study is designed to compare the efficacy and safety of once-daily oral administration of 200 milligrams of torezolid phosphate for six days of treatment with the efficacy and safety of twice-daily oral administration of 600 milligrams of linezolid (Zyvox®) for 10 days of treatment.

30 Aug 2010

PCEC coordinates free or low-cost prostate cancer screenings as part of PCAW

A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.

30 Aug 2010

Eisai receives new action date for FDA priority review of eribulin mesylate NDA for metastatic breast cancer

Eisai Inc. announced today that it has received notification from the U.S. Food and Drug Administration (FDA) that the agency expects to complete priority review of the eribulin mesylate New Drug Application (NDA) for locally advanced or metastatic breast cancer on or before December 30, 2010, which is a three month extension from the original Prescription Drug User Fee Act (PDUFA) action date of September 30, 2010.

30 Aug 2010

Kopp Drug chooses Activant Eagle software platform to be business management, POS solution

Activant Solutions Inc., a leading provider of retail and distribution business management solutions, today announced that Kopp Drug Inc. has selected the Activant Eagle® software platform to be its business management and Point-of-Sale solution. Kopp executives selected the Activant Eagle solution to help them improve inventory management and add operational efficiencies.

30 Aug 2010

Meda signs agreement to acquire Alaven

Meda has signed an agreement to acquire the US specialty pharmaceutical company Alaven. The acquisition will significantly enhance Meda's marketing capabilities in the US and expand the therapeutic focus to include both gastroenterology and women's health; areas that Meda already operates in outside of the US.

30 Aug 2010

Closing ceremony of heart transplant recipient's 700 km bicycle tour across Canada

Media representatives are invited to join us for the closing ceremony of heart transplant recipient Sylvain Bédard's bicycle tour, to take place at the Montreal Heart Institute (MHI). Dr. Michel Pellerin, the cardiac surgeon who performed the operation, will present him with an official MHI shirt as well as a bouquet of flowers to mark his accomplishment: a tour across Canada, 700 kilometres of which were done on bicycle.

30 Aug 2010

Industry experts to share knowledge on benefits of GIS systems

Carlos Zeferino Torreblanca Galindo, Governor of the State of Guerrero, Mexico and the former mayor of Acapulco spoke of the poverty within his state. Demographic data he showed put his state near the bottom of most statistics in basic services. Most support comes from the federal government but by the time the state uses funds to pay for basic services and debt finance, little is left to support services for the people.

From IQPC Ltd 30 Aug 2010

Bend Research granted patent for making solid amorphous dispersions of drugs with SDD technology

Bend Research Inc., a leading independent drug-formulation development and manufacturing company, announced today that it has received a new U.S. patent covering a process for making spray-dried solid amorphous dispersions of drugs using pressure nozzles.

30 Aug 2010

Patient Home Monitoring releases Reverse Take Over third quarter 2010 results

Patient Home Monitoring, a new company focused on in-home cardiology healthcare services, today released its post Reverse Take Over third quarter financial results, which primarily represent the period from the RTO on June 2, 2010 to June 30, 2010.

30 Aug 2010

Selective lowering of heart rate reduces risk of death and hospitalization: Study

The results of a major international study presented at the European Society of Cardiology Congress in Stockholm and published simultaneously in The Lancet show, for the first time, that selectively lowering heart rate with a novel medication, ivabradine, significantly reduces risk of death and hospitalization for patients with heart failure. This also resolves a longstanding debate about whether lowering heart rate itself can actually lower the risk of heart disease progression.

30 Aug 2010

Mobile Health Expo conference program highlights international nature of mobile health

Mobile Health Expo, the only event focusing on the convergence of mobile technology and healthcare across the entire mobile health ecosystem, today revealed some highlights from the conference program that focuses on the truly international nature of mobile health. Speakers representing both developing and developed nations will share case studies and best practices of how mobile health is being used in other countries.

30 Aug 2010

Covidien completes Specialty Chemicals Business sale for $280 million

Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Specialty Chemicals business to an affiliate of New Mountain Capital, L.L.C. for a cash purchase price of approximately $280 million.

30 Aug 2010

Pharmacists play major role in improving patients' health: Survey

A new international survey shows that over 90% of pharmacists believe they are key to improving patients' health, and while most pharmacists surveyed see their responsibilities increasing, they voice concerns on training and pay. The survey shows that almost 3 in 4 pharmacists (73%) now provide patients with health promotion and management services.

30 Aug 2010

Genzyme responds to Sanofi-Aventis' unsolicited acquisition proposal

Genzyme Corp. today confirmed that it has received an unsolicited, non-binding proposal from Sanofi-Aventis to acquire all the outstanding shares of Genzyme for $69 per share in cash. The Genzyme board of directors met last night, unanimously affirmed its previous rejection of Sanofi's proposal, and instructed the company to send Sanofi the following response letter:

30 Aug 2010

Genetic variations in Y chromosome affect men's risk of coronary heart disease: Scientists

Scientists in the UK have shown that genetic variations in the Y chromosome affect a male's risk of coronary heart disease. It is well known that males have a higher incidence of coronary heart disease than females due, in part, to the Y chromosome they inherit from their fathers. To investigate the role of the Y chromosome further, a team from the University of Leicester carried out research to determine whether genetic variations in the Y-chromosome affect risk for males.

30 Aug 2010

China Pharmaceuticals 2010 second quarter net sales increase 105%

China Pharmaceuticals, Inc., one of China's leading manufacturers and distributors of prescription and over-the-counter pharmaceuticals, today announced record financial results for its second quarter ended June 30, 2010.

30 Aug 2010

MedCath to sell interest in Avera Heart Hospital of South Dakota to Avera McKennan

MedCath Corporation announced today it has entered into a definitive agreement to sell its subsidiary which is the indirect owner of a one-third ownership interest and management rights in Avera Heart Hospital of South Dakota to Avera McKennan. The transaction is expected to close in 45 to 90 days, subject to certain closing conditions.

30 Aug 2010

Homewatch CareGivers releases new guide related to dementia care

As part of its ongoing program to help caregivers and provide families with the information they need to make informed decisions, Homewatch CareGivers has released its latest resource, entitled "Guide to Living with Dementia." This new guide is available for free download from the company's website.

30 Aug 2010

FDA approves additional strengths of SOLODYN for inflammatory lesions treatment

Medicis today announced that the U.S. Food and Drug Administration (FDA) has approved additional strengths of SOLODYN (minocycline HCl, USP) Extended Release Tablets in 55 mg, 80 mg and 105 mg dosages for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older.

30 Aug 2010

Medical News

Royal Philips Electronics launches new iE33 xMATRIX cardiac ultrasound system

Trius commences oral torezolid phosphate Phase 3 clinical study for ABSSSI

PCEC coordinates free or low-cost prostate cancer screenings as part of PCAW

Eisai receives new action date for FDA priority review of eribulin mesylate NDA for metastatic breast cancer

Kopp Drug chooses Activant Eagle software platform to be business management, POS solution

Meda signs agreement to acquire Alaven

Closing ceremony of heart transplant recipient's 700 km bicycle tour across Canada

Industry experts to share knowledge on benefits of GIS systems

Bend Research granted patent for making solid amorphous dispersions of drugs with SDD technology

Patient Home Monitoring releases Reverse Take Over third quarter 2010 results

Selective lowering of heart rate reduces risk of death and hospitalization: Study

Mobile Health Expo conference program highlights international nature of mobile health

Covidien completes Specialty Chemicals Business sale for $280 million

Pharmacists play major role in improving patients' health: Survey

Genzyme responds to Sanofi-Aventis' unsolicited acquisition proposal

Genetic variations in Y chromosome affect men's risk of coronary heart disease: Scientists

China Pharmaceuticals 2010 second quarter net sales increase 105%

MedCath to sell interest in Avera Heart Hospital of South Dakota to Avera McKennan

Homewatch CareGivers releases new guide related to dementia care

FDA approves additional strengths of SOLODYN for inflammatory lesions treatment

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News